Seattle nonprofit to battle cancer in Africa with help from biotech industry
Thursday, May 18, 2017
As progress is being made against deadly infectious diseases in Africa and other parts of the developed world, a new killer is rearing its head: cancer.
Cancer now kills more than 600,000 people on the African continent each year, 50 percent more than malaria, which has traditionally been one of the biggest public health concerns in Africa.
In response to this increase, Seattle nonprofit BIO Ventures for Global Health (BVGH) announced the African Access Initiative (AAI) Wednesday, which will enlist the aid of pharmaceutical and biotechnology companies in helping develop cancer treatment and R&D efforts in six countries in Africa.